TrialBMC cancer2021

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer.

Wanjun Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.